12 HR dalfampridine 10 MG Extended Release Oral Tablet
1 INDICATIONS AND USAGE Dalfampridine extended-release tablets are indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed [see Clinical Studies (14)]. Dalfampridine is a potassium channel blocker indicated to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed (1, 14).
sun pharmaceutical industries, inc.
ROUND WHITE 429
429 ROUND WHITE
Related Pills
ranitidine immediate release ranitidine tablet
strides shasun limited
Ranitidine 150 MG Oral Tablet
Strides Shasun Limited
Ranitidine 150 MG Oral Tablet
Strides Shasun Limited
ranitidine immediate release ranitidine tablet
Strides Shasun Limited
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
DALFAMPRIDINE extended-release tablets, 10 mg are white to off-white, round, biconvex, beveled edged, film-coated tablets imprinted with “429” in black ink on one side and plain on the other side. They are available as: Bottles of 60 with Child-resistant Cap ………….….. NDC 62756-429-86 Store
DALFAMPRIDINE extended-release tablets at 20° to 25°C (68° to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [see USP Controlled Room Temperature].
More pills like ROUND 429